Analysis of the assortment and the consumption volume of drugs for the treatment of erectile dysfunction in Ukraine

Authors

DOI:

https://doi.org/10.24959/cphj.18.1463

Keywords:

medicines for the treatment of erectile dysfunction, assortment, volumes of consumption, pharmaceutical market of Ukraine

Abstract

Erectile dysfunction (ED) is a pathological condition that affects millions of men around the world. According to the WHO statistics, not more than 20 % of men apply for problems with erectile dysfunction, and only a third of them agree to full treatment.

Aim. To analyze the assortment and study the volume of the drug consumption for the treatment of erectile dysfunction at the Ukrainian pharmaceutical market within 2014-2016.

Materials and methods. Drugs for the treatment of ED presented at the pharmaceutical market of Ukraine were analyzed according to the “Pharmstandard” analytical system of the pharmaceutical market research of MORION company. Volumes of drug consumption for the treatment of ED were studied using the ATC/DDD methodology recommended by the WHO. Data on DDD values are available on the WHO website.

Results. During 2014-2016 there was a decrease in the number of TNs from 133 TNs based on 6 INNs in 2014 to 121 TNs based on 6 INNs in 2016. According to the analysis of the volume of the drug consumption for the treatment of ED in DDDs/1000 inhabitants/day there was no increase in the consumption of these drugs during the study period (from 1.029 DDDs/1000 inhabitants/day in 2014 to 0.944 DDDs/1000 inhabitants/day in 2016). At the same time, the greatest share in the total drug consumption for ED treatment is typical for Sildenafil (the peak consumption in 2016 was 0.51 DDDs/1000 inhabitants/day).

Conclusions. Against the background of stability of the drug consumption for symptomatic treatment of ED during three years it has been found that in Ukraine there is a large number of patients who do not receive in full, or do not receive adequate ED treatment at all.

Author Biographies

L. V. Іakovlieva, National University of Pharmacy

Doctor of Pharmacy (Dr. habil.), professor, head of the Department of Pharmacoeconomics

O. G. Berdnik, National University of Pharmacy

teaching assistant of the Department of Pharmacoeconomics

References

1. World Health Organization. Available at: http://www.who.int/countries/ukr

2. Derzhavna sluzhba statystyky Ukrainy. (2018). Available at: www.ukrstat.gov.ua

Wespes, I., Amar, I., Dguliano, F. et al. (2011) Yevropeiskaia assotsiatsiia urologov, 51.

4. Systema doslidzhenia rynku likarskykh zasobiv «Farmstandart» kompanii «Morion». Available at: http://www.pharmstandart.com.ua

Morozov, A. M., Yakovlieva, L. V., Stepanenko, A. V. et al. (2013) Vyvchennia spozhyvannia likarskykh zasobiv za anatomo–terapevtychno– khimichnoiu klasyfikatsiieiu ta vstanovlenymy dobovymy dozamy (ATS/DDD– metodolohiia). Kharkiv: NUPh, DETs MOZ Ukrainy, 32.

Yakovlieva, L. V. (2009). Farmakoekonomika. Vinnytsia : Nova Knyha, 175–176.

Kovalev, V. A., Koroleva, S. V., Kachalov, A. A. (2009) Urologiia, 1, 33–38.

Aliaev, Yu. G., Vinarov, A. Z., Akhvlediani, N. D. (2005). Urologiia, 5, 64–66.

Halustian, Yu. M., Herasymenko, H. V., Makarova, O. V. (2011). Henderna statystyka Ukrainy: suchasnyi stan, problemy, napriamy vdoskonalennia. Zaporizhzhia : Drukarskyi svit, 192.

Malavige, L. S., Levy, J. C. (2009). Erectile Dysfunction in Diabetes Mellitus. The Journal of Sexual Medicine, 6 (5), 1232–1247. doi: 10.1111/j.1743–6109.2008.01168.x

Downloads

Published

2018-06-05

Issue

Vol. 22 No. 2 (2018)

Section

Pharmacoeconomics

License

Copyright (c) 2018 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).